SALLIE LIVELY: Open Payments
NPI 1063781714 · KINGSPORT, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,074 in 148 payments from 23 companies in 2025. Trend: 2023 $1,468 · 2024 $1,638 · 2025 $2,074
Food & beverage: $2,074
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 44 | $412 |
| GlaxoSmithKline, LLC. | 14 | $235 |
| AstraZeneca Pharmaceuticals LP | 8 | $189 |
| Amgen Inc. | 26 | $174 |
| Novo Nordisk Inc | 9 | $138 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $120 |
| Vanda Pharmaceuticals Inc. | 5 | $96 |
| Dexcom, Inc. | 1 | $86 |
| Exact Sciences Corporation | 4 | $86 |
| PFIZER INC. | 5 | $83 |
Products named: TRELEGY ELLIPTA, UBRELVY, VRAYLAR, FARXIGA, CAPLYTA, QULIPTA, OTEZLA, Dexcom G6 Transmitter.
Industry payments across TN — which companies pay providers there.
